Excited to be visiting Barcelona for #ESCMIDGlobal2024. Can't wait to get updates on key topics, the latest research from the past year, and connect with professionals and experts in the field of #ClinicalMicrobiology & #InfectiousDiseases
Let's connect!
Software, biologicals and hardware are the 3 pillars of your market access strategy. There are more than 20,000 new applications expected (IVDR/MDR) and only 42 notified bodies, with an expected 18 to 24 months lead time for approval.
Our team will be at analytica to discover the latest lab tech trends, network with industry leaders, and stay ahead of the curve.
Let's connect!
Remote monitoring revolutionizes In Vitro Diagnostics (IVD). Improve efficiency, guarantee data integrity, enhance compliance, optimize workflows. Explore the transformation.
For the next four years, Repado will contribute to the EU-funded project Pipeline for Rapid Diagnostics of Emergency Transboundary Infectious Diseases (PREPARE-TID) with the goal of developing and enabling rapid diagnostics for emergency transboundary infectious diseases.
Repado will be attending the SLAS 2024 International Conference and Exhibition, where Science and Technology Unite. SLAS is a global, non-profit professional community focused on leveraging the power of technology to achieve scientific objectives. SLAS's mission is to unite great minds in life sciences and technology to transform research.
See you there!
Repado is a certified software development house specialized in the Life Science and Healthcare Industry.
With more than 20 years’ experience in the MedTech field, we provide Software Development and Consultation services for regulated environments (MDR/IVDR).
The company is certified under ISO13485:2016 with primary objective the facilitation of harmonized medical device regulatory requirements for Quality Management Systems and ISO9001:2015 Certification for Software development and Implementation.
email: info@repado.com
